Skip to content
OpenCapital
Get started

Viatris VTRS Emerging Markets Segment — Net Sales

Other segment segments

Developed Markets Segment
$2.03B+6.7%
Greater China
$680.1M+22.4%
Japan, Australia and New Zealand Segment
$273.5M-1.3%

Similar metrics at other companies

The Kraft Heinz Company logo
KHCEmerging Markets Segment — Net Sales
$704.25M+1.8%
The Kraft Heinz Company logo
KHCEmerging Markets — Net Sales
$746M+7.5%
Brown-Forman Corporation logo
BF.AEmerging — Net Sales
$226M+10.2%
Danaher logo
DHRHigh-growth markets — Sales
$1.62B+5.7%
Envista Holdings Corporation logo
NVSTEmerging markets — Sales
$125M+5.2%
Pfizer logo
PFEInternational Emerging Markets — Revenues:
$2.29B+6.0%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.49B+81.7%
Enterprise value$31.3B+29.5%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%—
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity1×+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's emerging markets segment — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's emerging markets segment — net sales?
Viatris (VTRS) reported emerging markets segment — net sales of $537.4M in Q1 2026.
How has Viatris's emerging markets segment — net sales changed year-over-year?
Viatris's emerging markets segment — net sales increased by 2.7% year-over-year, from $523.1M to $537.4M.
What is the long-term trend for Viatris's emerging markets segment — net sales?
Over 4 years (2021 to 2025), Viatris's emerging markets segment — net sales has grown at a -8.4% compound annual growth rate (CAGR), from $3.14B to $2.22B.
What does emerging markets segment — net sales mean?
This metric represents the total revenue generated from the sale of pharmaceutical products within the company's designated emerging markets geographic segment. It reflects the company's ability to penetrate and grow market share in developing economies, which are often characterized by higher volume potential but different regulatory and pricing environments. Tracking this helps investors assess the geographic diversification and growth trajectory of the company's international footprint.